Will MolMed soon have its first Cell therapy on the Market?
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Small Cap Conference 2013: listed SMEs meet investors at Borsa Italiana
Relazione sulla Remunerazione MolMed S.p.A.
pg80-149_009.jpg
home | molmed
MolMed - YouTube
Overview of the Italian Primary Markets
Meeting agenda | molmed
European Population Genetic Substructure: Further Definition of Ancestry Informative Markers for Distinguishing among Diverse European Ethnic Groups | Molecular Medicine | Full Text
Molmed, opa della giapponese Agc per la biotech italiana Molmed - Wired | Wired Italia
Modeling early stage atherosclerosis in a primary human vascular microphysiological system | Nature Communications
COMUNICATO STAMPA
MolMed festeggia in Borsa: Germania conferma rimborsabilità Zalmoxis®
MolMed receives IND clearance by the FDA to conduct a Phase III trial of TK for high-risk leukaemia in the United States
COMUNICATO STAMPA
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHER
COMUNICATO STAMPA
MolMed - Wikipedia
Borsa, MolMed vola su espansione studio clinico in Usa - FIRSTonline
Will MolMed soon have its first Cell therapy on the Market?
Il 2019 è l'anno della svolta per MolMed - MilanoFinanza News
1 - [Note: this notice is the English translation of the official version of the 102 notice which will be in Italian language]